Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Horst Zincke

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Prostate-Specific Antigen

Physiology

Disease Progression

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
130
Blute, Michael
57
Leibovich, Bradley
55
Bergstralh, Erik
42
Lohse, Christine
41
Cheville, John
34
Bostwick, David
26
Sebo, Thomas
21
Frank, Igor
20
Sengupta, Shomik
19
Cheng, Liang
18
Kwon, Eugene
17
Slezak, Jeffrey
14
Thompson, Houston
14
Farrow, George
12
Lieber, Michael

Sign-in to see all Coauthors

Publications

TOP 3
Pisters Louis L; Leibovici Dan; Blute Michael; Zincke Horst; Sebo Thomas J; Slezak Jeffrey M; Izawa Jonathan; Ward John F; Scott Shellie M; Madsen Lydia; Spiess Philippe E; Leibovich Bradley C
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
Routh Jonathan C; Bacon Douglas R; Leibovich Bradley C; Zincke Horst; Blute Michael L; Frank Igor
How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery.
Chrouser Kristin; Leibovich Bradley; Bergstralh Erik; Zincke Horst; Blute Michael
Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Horst Zincke (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Pisters Louis L; Leibovici Dan; Blute Michael; Zincke Horst; Sebo Thomas J; Slezak Jeffrey M; Izawa Jonathan; Ward John F; Scott Shellie M; Madsen Lydia; Spiess Philippe E; Leibovich Bradley C
Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy.
The Journal of urology 2009;182(2):517-25; discussion 525-7.
2008: Routh Jonathan C; Bacon Douglas R; Leibovich Bradley C; Zincke Horst; Blute Michael L; Frank Igor
How long is too long? The effect of the duration of anaesthesia on the incidence of non-urological complications after surgery.
BJU international 2008;102(3):301-4.
2008: Chrouser Kristin; Leibovich Bradley; Bergstralh Erik; Zincke Horst; Blute Michael
Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
The Journal of urology 2008;179(5 Suppl):S7-S11.
2008: Sengupta Shomik; Blute Michael L; Bagniewski Stephanie M; Inman Brant; Leibovich Bradley C; Slezak Jeffrey M; Myers Robert P; Zincke Horst
After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
BJU international 2008;101(2):170-4.
2007: Molina Julian R; Quevedo J Fernando; Furth Alfred F; Richardson Ronald L; Zincke Horst; Burch Patrick A
Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
Cancer 2007;110(11):2434-40.
2007: Siddiqui Sameer A; Mynderse Lance A; Zincke Horst; Hoffmann Nathan E; Lobo John R; Wilson Torrence M; Kawashima Akira; Davis Brian J; Blute Michael L
Treatment of prostate cancer local recurrence after radical retropubic prostatectomy with 17-gauge interstitial transperineal cryoablation: initial experience.
Urology 2007;70(1):80-5.
2007: Krambeck Amy E; Thompson R Houston; Lohse Christine M; Patterson David E; Segura Joseph W; Zincke Horst; Elliott Daniel S; Blute Michael L
Endoscopic management of upper tract urothelial carcinoma in patients with a history of bladder urothelial carcinoma.
The Journal of urology 2007;177(5):1721-6.
2007: Tollefson Matthew K; Slezak Jeffrey M; Leibovich Bradley C; Zincke Horst; Blute Michael L
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomy.
Mayo Clinic proceedings. Mayo Clinic 2007;82(4):422-7.
2007: Thompson R Houston; Leibovich Bradley C; Lohse Christine M; Cheville John C; Zincke Horst; Blute Michael L; Frank Igor
Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score.
The Journal of urology 2007;177(2):477-80.
2007: Thompson R Houston; Frank Igor; Lohse Christine M; Saad Ismail R; Fergany Amr; Zincke Horst; Leibovich Bradley C; Blute Michael L; Novick Andrew C
The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study.
The Journal of urology 2007;177(2):471-6.
2007: Siddiqui Sameer A; Frank Igor; Leibovich Bradley C; Cheville John C; Lohse Christine M; Zincke Horst; Blute Michael L
Impact of tumor size on the predictive ability of the pT3a primary tumor classification for renal cell carcinoma.
The Journal of urology 2007;177(1):59-62.
2006: Krambeck Amy E; Leibovich Bradley C; Lohse Christine M; Kwon Eugene D; Zincke Horst; Blute Michael L
The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
The Journal of urology 2006;176(5):1990-5; discussion 1995.
2006: Inman Brant A; DiMarco David S; Slezak Jeffrey M; Sebo Thomas J; Kwon Eugene D; Leibovich Bradley C; Blute Michael L; Zincke Horst
Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy.
Urology 2006;68(3):604-8.
2006: Siddiqui Sameer A; Sengupta Shomik; Slezak Jeffrey M; Bergstralh Eric J; Zincke Horst; Blute Michael L
Impact of familial and hereditary prostate cancer on cancer specific survival after radical retropubic prostatectomy.
The Journal of urology 2006;176(3):1118-21.
2006: Thompson R Houston; Leibovich Bradley C; Cheville John C; Webster W Scott; Lohse Christine M; Kwon Eugene D; Zincke Horst; Blute Michael L
Second primary malignancies associated with renal cell carcinoma histological subtypes.
The Journal of urology 2006;176(3):900-3; discussion 903-4.
2006: Sengupta Shomik; Zincke Horst
Is nephron-sparing surgery for small renal masses underused?
Nature clinical practice. Urology 2006;3(8):412-3.
2006: Ashley Richard A; Inman Brant A; Sebo Thomas J; Leibovich Bradley C; Blute Michael L; Kwon Eugene D; Zincke Horst
Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy.
Cancer 2006;107(4):712-20.
2006: Sengupta Shomik; Christensen Carl M; Zincke Horst; Slezak Jeffrey M; Leibovich Bradley C; Bergstralh Eric J; Myers Robert P; Blute Michael L
Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significance.
The Journal of urology 2006;176(2):559-63.
2006: Siddiqui Sameer A; Inman Brant A; Sengupta Shomik; Slezak Jeffrey M; Bergstralh Eric J; Leibovich Bradley C; Zincke Horst; Blute Michael L
Obesity and survival after radical prostatectomy: A 10-year prospective cohort study.
Cancer 2006;107(3):521-9.
2006: Sengupta Shomik; Cheville John C; Lohse Christine M; Zincke Horst; Myers Robert P; Riehle Darren L; Pankratz V Shane; Blute Michael L; Sebo Thomas J
Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Urology 2006;68(1):94-8.
2006: Sengupta Shomik; Slezak Jeffrey M; Blute Michael L; Leibovich Bradley C; Sebo Thomas J; Myers Robert P; Cheville John C; Bergstralh Eric J; Zincke Horst
Trends in distribution and prognostic significance of Gleason grades on radical retropubic prostatectomy specimens between 1989 and 2001.
Cancer 2006;106(12):2630-5.
2006: Sengupta Shomik; Blute Michael L; Bagniewski Stephanie M; Myers Robert P; Bergstralh Eric J; Leibovich Bradley C; Zincke Horst
Increasing prostate specific antigen following radical prostatectomy and adjuvant hormonal therapy: doubling time predicts survival.
The Journal of urology 2006;175(5):1684-90; discussion 1690.
2006: Thompson R Houston; Kuntz Susan M; Leibovich Bradley C; Dong Haidong; Lohse Christine M; Webster W Scott; Sengupta Shomik; Frank Igor; Parker Alexander S; Zincke Horst; Blute Michael L; Sebo Thomas J; Cheville John C; Kwon Eugene D
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
Cancer research 2006;66(7):3381-5.
2006: Siddiqui Sameer A; Sengupta Shomik; Slezak Jeffrey M; Bergstralh Eric J; Leibovich Bradley C; Myers Robert P; Zincke Horst; Blute Michael L
Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancer.
The Journal of urology 2006;175(3 Pt 1):952-7.
2006: Tollefson Matthew K; Leibovich Bradley C; Slezak Jeffrey M; Zincke Horst; Blute Michael L
Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival.
The Journal of urology 2006;175(2):547-51.
2006: Sengupta Shomik; Cheville John C; Corless Christopher L; Lohse Christine M; Heinrich Michael C; Kwon Eugene D; Zincke Horst; Blute Michael L; Leibovich Bradley C
Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma.
The Journal of urology 2006;175(1):53-6.
2006: Sengupta Shomik; Lohse Christine M; Cheville John C; Leibovich Bradley C; Thompson R Houston; Webster W Scott; Frank Igor; Zincke Horst; Blute Michael L; Kwon Eugene D
The preoperative erythrocyte sedimentation rate is an independent prognostic factor in renal cell carcinoma.
Cancer 2006;106(2):304-12.
2005: Sengupta Shomik; Zincke Horst
Is radical prostatectomy of benefit in men with localized prostate cancer?
Nature clinical practice. Oncology 2005;2(12):608-9.
2005: Sengupta Shomik; Zincke Horst; Blute Michael L
Re: The accuracy of 250 fine needle biopsies of renal tumors.
The Journal of urology 2005;174(6):2422; author reply 2422.
2005: Sengupta Shomik; Myers Robert P; Slezak Jeffrey M; Bergstralh Eric J; Zincke Horst; Blute Michael L
Preoperative prostate specific antigen doubling time and velocity are strong and independent predictors of outcomes following radical prostatectomy.
The Journal of urology 2005;174(6):2191-6.
2005: Leibovich Bradley C; Cheville John C; Lohse Christine M; Zincke Horst; Frank Igor; Kwon Eugene D; Merchan Jaime R; Blute Michael L
A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
The Journal of urology 2005;174(5):1759-63; discussion 1763.
2005: Thompson R Houston; Gillett Michael D; Cheville John C; Lohse Christine M; Dong Haidong; Webster W Scott; Chen Lieping; Zincke Horst; Blute Michael L; Leibovich Bradley C; Kwon Eugene D
Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.
Cancer 2005;104(10):2084-91.
2005: Sengupta Shomik; Zincke Horst
Lessons learned in the surgical management of renal cell carcinoma.
Urology 2005;66(5 Suppl):36-42.
2005: Thompson R Houston; Leibovich Bradley C; Cheville John C; Webster W Scott; Lohse Christine M; Kwon Eugene D; Frank Igor; Zincke Horst; Blute Michael L
Is renal sinus fat invasion the same as perinephric fat invasion for pT3a renal cell carcinoma?
The Journal of urology 2005;174(4 Pt 1):1218-21.
2005: Thompson R Houston; Leibovich Bradley C; Lohse Christine M; Zincke Horst; Blute Michael L
Complications of contemporary open nephron sparing surgery: a single institution experience.
The Journal of urology 2005;174(3):855-8.
2005: Sengupta Shomik; Lohse Christine M; Leibovich Bradley C; Frank Igor; Thompson R Houston; Webster W Scott; Zincke Horst; Blute Michael L; Cheville John C; Kwon Eugene D
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.
Cancer 2005;104(3):511-20.
2005: Sengupta Shomik; Leibovich Bradley C; Blute Michael L; Zincke Horst
Surgery for metastatic renal cell cancer.
World journal of urology 2005;23(3):155-60.
2005: Sengupta Shomik; Zincke Horst; Leibovich Bradley C; Blute Michael L
Surgical treatment of stage pT3b renal cell carcinoma in solitary kidneys: a case series.
BJU international 2005;96(1):54-7.
2005: Chrouser Kristin; Leibovich Bradley; Bergstralh Erik; Zincke Horst; Blute Michael
Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
The Journal of urology 2005;174(1):107-10; discussion 110-1.
2005: Thompson R Houston; Cheville John C; Lohse Christine M; Webster W Scott; Zincke Horst; Kwon Eugene D; Frank Igor; Blute Michael L; Leibovich Bradley C
Reclassification of patients with pT3 and pT4 renal cell carcinoma improves prognostic accuracy.
Cancer 2005;104(1):53-60.
2005: Chrouser Kristin L; Leibovich Bradley C; Sweat Susan D; Larson David W; Davis Brian J; Tran Nho V; Zincke Horst; Blute Michael L
Urinary fistulas following external radiation or permanent brachytherapy for the treatment of prostate cancer.
The Journal of urology 2005;173(6):1953-7.
2005: Gillett Michael D; Cheville John C; Karnes R Jeffrey; Lohse Christine M; Kwon Eugene D; Leibovich Bradley C; Zincke Horst; Blute Michael L
Comparison of presentation and outcome for patients 18 to 40 and 60 to 70 years old with solid renal masses.
The Journal of urology 2005;173(6):1893-6.
2005: Frank Igor; Blute Michael L; Leibovich Bradley C; Cheville John C; Lohse Christine M; Zincke Horst
Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, single institution cohort.
The Journal of urology 2005;173(6):1889-92.
2005: Krambeck Amy E; Farrell Michael A; Charboneau J W; Frank Igor; Zincke Horst
Intraperitoneal drop metastasis after radiofrequency ablation of pararenal tumor recurrences.
Urology 2005;65(4):797.
2005: Ward John F; Slezak Jeffrey M; Blute Michael L; Bergstralh Erik J; Zincke Horst
Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome.
BJU international 2005;95(6):751-6.
2005: Ward John F; Sebo Thomas J; Blute Michael L; Zincke Horst
Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes.
The Journal of urology 2005;173(4):1156-60.
2005: DiMarco David S; Zincke Horst; Sebo Thomas J; Slezak Jeffrey; Bergstralh Erik J; Blute Michael L
The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
The Journal of urology 2005;173(4):1121-5.
2005: Thompson R Houston; Leibovich Bradley C; Cheville John C; Lohse Christine M; Frank Igor; Kwon Eugene D; Zincke Horst; Blute Michael L
Should direct ipsilateral adrenal invasion from renal cell carcinoma be classified as pT3a?
The Journal of urology 2005;173(3):918-21.
2005: Leibovich Bradley C; Cheville John C; Lohse Christine M; Zincke Horst; Kwon Eugene D; Frank Igor; Thompson R Houston; Blute Michael L
Cancer specific survival for patients with pT3 renal cell carcinoma-can the 2002 primary tumor classification be improved?
The Journal of urology 2005;173(3):716-9.
2005: Kipp Benjamin R; Karnes R Jeffrey; Brankley Shannon M; Harwood Aaron R; Pankratz V Shane; Sebo Thomas J; Blute Michael M; Lieber Michael M; Zincke Horst; Halling Kevin C
Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.
The Journal of urology 2005;173(2):401-4.
2005: Bani-Hani Ahmad H; Leibovich Bradley C; Lohse Christine M; Cheville John C; Zincke Horst; Blute Michael L
Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients.
The Journal of urology 2005;173(2):391-4.
2005: Frank Igor; Blute Michael L; Leibovich Bradley C; Cheville John C; Lohse Christine M; Kwon Eugene D; Zincke Horst
pT2 classification for renal cell carcinoma. Can its accuracy be improved?
The Journal of urology 2005;173(2):380-4.
2004: Gillett Michael D; Gettman Matthew T; Zincke Horst; Blute Michael L
Tissue ablation technologies for localized prostate cancer.
Mayo Clinic proceedings. Mayo Clinic 2004;79(12):1547-55.
2004: Thompson R Houston; Gillett Michael D; Cheville John C; Lohse Christine M; Dong Haidong; Webster W Scott; Krejci Kent G; Lobo John R; Sengupta Shomik; Chen Lieping; Zincke Horst; Blute Michael L; Strome Scott E; Leibovich Bradley C; Kwon Eugene D
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(49):17174-9.
2004: Ward John F; Zincke Horst; Bergstralh Erik J; Slezak Jeffrey M; Blute Michael L
Prostate specific antigen doubling time subsequent to radical prostatectomy as a prognosticator of outcome following salvage radiotherapy.
The Journal of urology 2004;172(6 Pt 1):2244-8.
2004: Routh Jonathan C; Leibovich Bradley C; Zincke Horst; Blute Micheal L
Nephron-sparing surgery and renal cell carcinoma.
JAMA : the journal of the American Medical Association 2004;292(14):1684; author reply 1684.
2004: Frank Igor; Cheville John C; Blute Michael L; Lohse Christine M; Karnes R Jeffrey; Weaver Amy L; Sebo Thomas J; Nehra Ajay; Zincke Horst
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement.
Cancer 2004;101(8):1803-8.
2004: Ward John F; Zincke Horst; Bergstralh Erik J; Slezak Jeffrey M; Myers Robert P; Blute Michael L
The impact of surgical approach (nerve bundle preservation versus wide local excision) on surgical margins and biochemical recurrence following radical prostatectomy.
The Journal of urology 2004;172(4 Pt 1):1328-32.
2004: Dimarco David S; Dimarco Connie S; Zincke Horst; Webb Maurice J; Bass Sarah E; Slezak Jeffrey M; Lightner Deborah J
Surgical treatment for local control of female urethral carcinoma.
Urologic oncology 2004;22(5):404-9.
2004: Humphreys Mitchell R; Gettman Matthew T; Chow George K; Zincke Horst; Blute Michael L
Minimally invasive radical prostatectomy.
Mayo Clinic proceedings. Mayo Clinic 2004;79(9):1169-80.
2004: Dimarco David S; Lohse Christine M; Zincke Horst; Cheville John C; Blute Michael L
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.
Urology 2004;64(3):462-7.
2004: Blute Michael L; Leibovich Bradley C; Cheville John C; Lohse Christine M; Zincke Horst
A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma.
The Journal of urology 2004;172(2):465-9.
2004: Blute Michael L; Leibovich Bradley C; Lohse Christine M; Cheville John C; Zincke Horst
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus.
BJU international 2004;94(1):33-41.
2004: Cheville John C; Lohse Christine M; Zincke Horst; Weaver Amy L; Leibovich Bradley C; Frank Igor; Blute Michael L
Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
The American journal of surgical pathology 2004;28(4):435-41.
2004: Leibovich Bradley C; Blute Michael L; Cheville John C; Lohse Christine M; Weaver Amy L; Zincke Horst
Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
The Journal of urology 2004;171(3):1066-70.
2004: DiMarco David S; DiMarco Connie S; Zincke Horst; Webb Maurice J; Keeney Gary L; Bass Sarah; Lightner Deborah J
Outcome of surgical treatment for primary malignant melanoma of the female urethra.
The Journal of urology 2004;171(2 Pt 1):765-7.
2004: Ward John F; Bartsch George; Sebo Thomas J; Pinggera Germar-Michael; Blute Michael L; Zincke Horst
Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0-2 ng/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance?
Urologic oncology 2004;22(1):40-7.
2003: Frank Igor; Blute Michael L; Cheville John C; Lohse Christine M; Weaver Amy L; Leibovich Bradley C; Zincke Horst
A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma.
The Journal of urology 2003;170(6 Pt 1):2225-32.
2003: Frank Igor; Blute Michael L; Cheville John C; Lohse Christine M; Weaver Amy L; Zincke Horst
Solid renal tumors: an analysis of pathological features related to tumor size.
The Journal of urology 2003;170(6 Pt 1):2217-20.
2003: DiMarco David S; Blute Michael L; Zincke Horst; Cheville John C; Riehle Darren L; Lohse Christine M; Pankratz V Shane; Sebo Thomas J
Multivariate models to predict clinically important outcomes at prostatectomy for patients with organ-confined disease and needle biopsy Gleason scores of 6 or less.
Urologic oncology 2003;21(6):439-46.
2003: Ward John F; Blute Michael L; Slezak Jeffrey; Bergstralh Erik J; Zincke Horst
The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
The Journal of urology 2003;170(5):1872-6.
2003: Krejci Kent G; Blute Michael L; Cheville John C; Sebo Thomas J; Lohse Christine M; Zincke Horst
Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Urology 2003;62(4):641-6.
2003: Han Ken-Ryu; Cohen Jeff K; Miller Ralph J; Pantuck Allan J; Freitas Danielo G; Cuevas Carlos A; Kim Hyung L; Lugg James; Childs Stacy J; Shuman Barry; Jayson Maury A; Shore Neal D; Moore Yan; Zisman Amnon; Lee Joe Y; Ugarte Roland; Mynderse Lance A; Wilson Torrence M; Sweat Susan D; Zincke Horst; Belldegrun Arie S
Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience.
The Journal of urology 2003;170(4 Pt 1):1126-30.
2003: Blute Michael L; Thibault Gregory P; Leibovich Bradley C; Cheville John C; Lohse Christine M; Zincke Horst
Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence.
The Journal of urology 2003;170(3):760-3.
2003: Lau W K; Zincke H; Lohse C M; Cheville J C; Weaver A L; Blute M L
Contralateral adrenal metastasis of renal cell carcinoma: treatment, outcome and a review.
BJU international 2003;91(9):775-9.
2003: Ward John F; Zincke Horst
Radical prostatectomy for the patient with locally advanced prostate cancer.
Current urology reports 2003;4(3):196-204.
2003: Frank Igor; Cheville John C; Blute Michael L; Lohse Christine M; Nehra Ajay; Weaver Amy L; Karnes R Jeffrey; Zincke Horst
Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome.
Cancer 2003;97(10):2425-31.
2003: Cheville John C; Lohse Christine M; Zincke Horst; Weaver Amy L; Blute Michael L
Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.
The American journal of surgical pathology 2003;27(5):612-24.
2003: Melton L Joseph; Alothman Khalid I; Khosla Sundeep; Achenbach Sara J; Oberg Ann L; Zincke Horst
Fracture risk following bilateral orchiectomy.
The Journal of urology 2003;169(5):1747-50.
2003: Leibovich Bradley C; Blute Michael L; Cheville John C; Lohse Christine M; Frank Igor; Kwon Eugene D; Weaver Amy L; Parker Alexander S; Zincke Horst
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.
Cancer 2003;97(7):1663-71.
2003: Gettman Matthew T; Boelter Christopher W; Cheville John C; Zincke Horst; Bryant Sandra C; Blute Michael L
Charlson co-morbidity index as a predictor of outcome after surgery for renal cell carcinoma with renal vein, vena cava or right atrium extension.
The Journal of urology 2003;169(4):1282-6.
2003: Blute Michael L; Itano Nancy B; Cheville John C; Weaver Amy L; Lohse Christine M; Zincke Horst
The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
The Journal of urology 2003;169(4):1276-81.
2003: Dechet Christopher B; Zincke Horst; Sebo Thomas J; King Bernard F; LeRoy Andrew J; Farrow George M; Blute Michael L
Prospective analysis of computerized tomography and needle biopsy with permanent sectioning to determine the nature of solid renal masses in adults.
The Journal of urology 2003;169(1):71-4.
2002: Lohse Christine M; Blute Michael L; Zincke Horst; Weaver Amy L; Cheville John C
Comparison of standardized and nonstandardized nuclear grade of renal cell carcinoma to predict outcome among 2,042 patients.
American journal of clinical pathology 2002;118(6):877-86.
2002: Frank Igor; Blute Michael L; Cheville John C; Lohse Christine M; Weaver Amy L; Zincke Horst
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.
The Journal of urology 2002;168(6):2395-400.
2002: Kausik Sankar J; Blute Michael L; Sebo Thomas J; Leibovich Bradley C; Bergstralh Erik J; Slezak Jeff; Zincke Horst
Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy.
Cancer 2002;95(6):1215-9.
2002: Bostwick David G; Qian Junqi; Pacelli Anna; Zincke Horst; Blute Michael; Bergstralh Erik J; Slezak Jeffrey M; Cheng Liang
Neuroendocrine expression in node positive prostate cancer: correlation with systemic progression and patient survival.
The Journal of urology 2002;168(3):1204-11.
2002: Pisansky Thomas M; Blute Michael L; Hillman David W; Davis Brian J; Haddock Michael G; Suman Vera J; Wilson Torrence M; Zincke Horst
The relevance of prostatectomy findings for brachytherapy selection in patients with localized prostate carcinoma.
Cancer 2002;95(3):513-9.
2002: Sweat Susan D; Bergstralh Erik J; Slezak Jeffrey; Blute Michael L; Zincke Horst
Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age.
The Journal of urology 2002;168(2):525-9.
2002: Ghavamian Reza; Cheville John C; Lohse Christine M; Weaver Amy L; Zincke Horst; Blute Michael L
Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
The Journal of urology 2002;168(2):454-9.
2002: Ward John F; Blute Michael L; Cheville John C; Lohse Christine M; Weaver Amy L; Zincke Horst
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
The Journal of urology 2002;168(1):56-60.
2002: Halling Kevin C; King Walter; Sokolova Irina A; Karnes R Jeffrey; Meyer Reid G; Powell Eric L; Sebo Thomas J; Cheville John C; Clayton Amy C; Krajnik Kelly L; Ebert Thomas A; Nelson Robert E; Burkhardt Haleh M; Ramakumar Sanjay; Stewart Christopher S; Pankratz Vernon S; Lieber Michael M; Blute Michael L; Zincke Horst; Seelig Steven A; Jenkins Robert B; O'Kane Dennis J
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
The Journal of urology 2002;167(5):2001-6.
2002: Cheville John C; Zincke Horst; Lohse Christine M; Sebo Thomas J; Riehle Darren; Weaver Amy L; Blute Michael L
pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
Cancer 2002;94(8):2180-4.
2002: Lau Weber K; Cheville John C; Blute Michael L; Weaver Amy L; Zincke Horst
Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Urology 2002;59(4):532-7.
2002: Sebo Thomas J; Cheville John C; Riehle Darren L; Lohse Christine M; Pankratz V Shane; Myers Robert P; Blute Michael L; Zincke Horst
Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer.
The American journal of surgical pathology 2002;26(4):431-9.
2002: Lerner Seth E; Hawkins Craig A; Blute Michael L; Grabner Andreas; Wollan Peter C; Eickholt Jeffrey T; Zincke Horst
Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. 1996.
The Journal of urology 2002;167(2 Pt 2):884-9; discussion 889-90.
2002: Lau Weber K; Bergstralh Erik J; Blute Michael L; Slezak Jeffrey M; Zincke Horst
Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables.
The Journal of urology 2002;167(1):117-22.
2001: Melton L J; Alothman K I; Achenbach S J; O'Fallon W M; Zincke H
Decline in bilateral orchiectomy for prostate cancer in Olmsted county, Minnesota, 1956-2000.
Mayo Clinic proceedings. Mayo Clinic 2001;76(12):1199-203.
2001: Zincke H; Lau W; Bergstralh E; Blute M L
Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer.
The Journal of urology 2001;166(6):2208-15.
2001: Roberts S G; Blute M L; Bergstralh E J; Slezak J M; Zincke H
PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Mayo Clinic proceedings. Mayo Clinic 2001;76(6):576-81.
2001: Sebo T J; Cheville J C; Riehle D L; Lohse C M; Pankratz V S; Myers R P; Blute M L; Zincke H
Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases.
Cancer 2001;91(11):2196-204.
2001: Ghavamian R; Zincke H
Open surgical partial nephrectomy.
Seminars in urologic oncology 2001;19(2):103-13.
2001: Ghavamian R; Zincke H
Nephron-sparing surgery.
Current urology reports 2001;2(1):34-9.
2001: Gettman M T; Blute M L; Spotts B; Bryant S C; Zincke H
Pathologic staging of renal cell carcinoma: significance of tumor classification with the 1997 TNM staging system.
Cancer 2001;91(2):354-61.
2001: Cheng L; Zincke H; Blute M L; Bergstralh E J; Scherer B; Bostwick D G
Risk of prostate carcinoma death in patients with lymph node metastasis.
Cancer 2001;91(1):66-73.
2001: Blute M L; Bergstralh E J; Iocca A; Scherer B; Zincke H
Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.
The Journal of urology 2001;165(1):119-25.
2001: Torres V E; King B F; McKusick M A; Bjornsson J; Zincke H
Update on tuberous sclerosis complex.
Contributions to nephrology 2001;(136):33-49.
2000: Lau W K; Blute M L; Weaver A L; Torres V E; Zincke H
Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.
Mayo Clinic proceedings. Mayo Clinic 2000;75(12):1236-42.
2000: Leibovich B C; Blute M L; Bostwick D G; Wilson T M; Pisansky T M; Davis B J; Ramnani D M; Cheng L; Sebo T J; Zincke H
Proximity of prostate cancer to the urethra: implications for minimally invasive ablative therapies.
Urology 2000;56(5):726-9.
2000: Blute M L; Bergstralh E J; Partin A W; Walsh P C; Kattan M W; Scardino P T; Montie J E; Pearson J D; Slezak J M; Zincke H
Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
The Journal of urology 2000;164(5):1591-5.
2000: Blute M L; Amling C L; Bryant S C; Zincke H
Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Mayo Clinic proceedings. Mayo Clinic 2000;75(10):1020-6.
2000: Cheng L; Slezak J; Bergstralh E J; Myers R P; Zincke H; Bostwick D G
Preoperative prediction of surgical margin status in patients with prostate cancer treated by radical prostatectomy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(15):2862-8.
2000: Itano N B; Blute M L; Spotts B; Zincke H
Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
The Journal of urology 2000;164(2):322-5.
2000: Amling C L; Blute M L; Bergstralh E J; Seay T M; Slezak J; Zincke H
Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
The Journal of urology 2000;164(1):101-5.
2000: Ghavamian R; Klein K A; Stephens D H; Welch T J; LeRoy A J; Richardson R L; Burch P A; Zincke H
Renal cell carcinoma metastatic to the pancreas: clinical and radiological features.
Mayo Clinic proceedings. Mayo Clinic 2000;75(6):581-5.
2000: Cheng L; Weaver A L; Leibovich B C; Ramnani D M; Neumann R M; Scherer B G; Nehra A; Zincke H; Bostwick D G
Predicting the survival of bladder carcinoma patients treated with radical cystectomy.
Cancer 2000;88(10):2326-32.
2000: Cheng L; Lloyd R V; Weaver A L; Pisansky T M; Cheville J C; Ramnani D M; Leibovich B C; Blute M L; Zincke H; Bostwick D G
The cell cycle inhibitors p21WAF1 and p27KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1896-9.
2000: Cheng L; Leibovich B C; Cheville J C; Ramnani D M; Sebo T J; Nehra A; Malek R S; Zincke H; Bostwick D G
Squamous papilloma of the urinary tract is unrelated to condyloma acuminata.
Cancer 2000;88(7):1679-86.
2000: Leibovich B C; Engen D E; Patterson D E; Pisansky T M; Alexander E E; Blute M L; Bergstralh E J; Zincke H
Benefit of adjuvant radiation therapy for localized prostate cancer with a positive surgical margin.
The Journal of urology 2000;163(4):1178-82.
2000: Cheng L; Pisansky T M; Ramnani D M; Leibovich B C; Cheville J C; Slezak J; Bergstralh E J; Zincke H; Bostwick D G
Extranodal extension in lymph node-positive prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(2):113-8.
2000: Cheng L; Leibovich B C; Cheville J C; Ramnani D M; Sebo T J; Neumann R M; Nascimento A G; Zincke H; Bostwick D G
Paraganglioma of the urinary bladder: can biologic potential be predicted?
Cancer 2000;88(4):844-52.
2000: Cheng L; Neumann R M; Weaver A L; Cheville J C; Leibovich B C; Ramnani D M; Scherer B G; Nehra A; Zincke H; Bostwick D G
Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.
American journal of clinical pathology 2000;113(2):275-9.
2000: Sebo T J; Bock B J; Cheville J C; Lohse C; Wollan P; Zincke H
The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
The Journal of urology 2000;163(1):174-8.
1999: Cheng L; Darson M; Cheville J C; Neumann R M; Zincke H; Nehra A; Bostwick D G
Urothelial papilloma of the bladder. Clinical and biologic implications.
Cancer 1999;86(10):2098-101.
1999: Cheng L; Pisansky T M; Sebo T J; Leibovich B C; Ramnani D M; Weaver A L; Scherer B G; Blute M L; Zincke H; Bostwick D G
Cell proliferation in prostate cancer patients with lymph node metastasis: a marker for progression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2820-3.
1999: Dechet C B; Sebo T; Farrow G; Blute M L; Engen D E; Zincke H
Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults.
The Journal of urology 1999;162(4):1282-4; discussion 1284-5.
1999: Gettman M T; Pacelli A; Slezak J; Bergstralh E J; Blute M; Zincke H; Bostwick D G
Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
Urology 1999;54(3):479-85.
1999: Cheng L; Slezak J; Bergstralh E J; Cheville J C; Sweat S; Zincke H; Bostwick D G
Dedifferentiation in the metastatic progression of prostate carcinoma.
Cancer 1999;86(4):657-63.
1999: Ghavamian R; Blute M L; Bergstralh E J; Slezak J; Zincke H
Comparison of clinically nonpalpable prostate-specific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy.
Urology 1999;54(1):105-10.
1999: Cheng L; Cheville J C; Pisansky T M; Sebo T J; Slezak J; Bergstralh E J; Neumann R M; Singh R; Pacelli A; Zincke H; Bostwick D G
Prevalence and distribution of prostatic intraepithelial neoplasia in salvage radical prostatectomy specimens after radiation therapy.
The American journal of surgical pathology 1999;23(7):803-8.
1999: Dechet C B; Bostwick D G; Blute M L; Bryant S C; Zincke H
Renal oncocytoma: multifocality, bilateralism, metachronous tumor development and coexistent renal cell carcinoma.
The Journal of urology 1999;162(1):40-2.
1999: Cheng L; Neumann R M; Scherer B G; Weaver A L; Leibovich B C; Nehra A; Zincke H; Bostwick D G
Tumor size predicts the survival of patients with pathologic stage T2 bladder carcinoma: a critical evaluation of the depth of muscle invasion.
Cancer 1999;85(12):2638-47.
1999: Cheng L; Leibovich B C; Bergstralh E J; Scherer B G; Pacelli A; Ramnani D M; Zincke H; Bostwick D G
p53 alteration in regional lymph node metastases from prostate carcinoma: a marker for progression?
Cancer 1999;85(11):2455-9.
1999: Ghavamian R; Bergstralh E J; Blute M L; Slezak J; Zincke H
Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison.
The Journal of urology 1999;161(4):1223-7; discussion 1227-8.
1999: Cheng L; Bergstralh E J; Scherer B G; Neumann R M; Blute M L; Zincke H; Bostwick D G
Predictors of cancer progression in T1a prostate adenocarcinoma.
Cancer 1999;85(6):1300-4.
1999: Cheng L; Sebo T J; Cheville J C; Pisansky T M; Slezak J; Bergstralh E J; Pacelli A; Neumann R M; Zincke H; Bostwick D G
p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
Cancer 1999;85(6):1293-9.
1999: Amling C L; Lerner S E; Martin S K; Slezak J M; Blute M L; Zincke H
Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
The Journal of urology 1999;161(3):857-62; discussion 862-3.
1999: Corica F A; Iczkowski K A; Cheng L; Zincke H; Blute M L; Wendel A; Sebo T J; Neumann R; Bostwick D G
Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup.
The Journal of urology 1999;161(2):408-11.
1998: Cheng L; Bergstralh E J; Cheville J C; Slezak J; Corica F A; Zincke H; Blute M L; Bostwick D G
Cancer volume of lymph node metastasis predicts progression in prostate cancer.
The American journal of surgical pathology 1998;22(12):1491-500.
1998: Cheng L; Sebo T J; Slezak J; Pisansky T M; Bergstralh E J; Neumann R M; Iczkowski K A; Zincke H; Bostwick D G
Predictors of survival for prostate carcinoma patients treated with salvage radical prostatectomy after radiation therapy.
Cancer 1998;83(10):2164-71.
1998: Torres V E; Bjornsson J; Zincke H
Inherited renal neoplasms.
Journal of nephrology 1998;11(5):229-38.
1998: Amling C L; Blute M L; Lerner S E; Bergstralh E J; Bostwick D G; Zincke H
Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice.
Mayo Clinic proceedings. Mayo Clinic 1998;73(5):401-6.
1998: Lopez-Beltran A; Pacelli A; Rothenberg H J; Wollan P C; Zincke H; Blute M L; Bostwick D G
Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
The Journal of urology 1998;159(5):1497-503.
1998: Blute M L; Bostwick D G; Seay T M; Martin S K; Slezak J M; Bergstralh E J; Zincke H
Pathologic classification of prostate carcinoma: the impact of margin status.
Cancer 1998;82(5):902-8.
1998: Seay T M; Blute M L; Zincke H
Long-term outcome in patients with pTxN+ adenocarcinoma of prostate treated with radical prostatectomy and early androgen ablation.
The Journal of urology 1998;159(2):357-64.
1998: Gettman M T; Bergstralh E J; Blute M; Zincke H; Bostwick D G
Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate: lack of significance for microvessel density analysis.
Urology 1998;51(1):79-85.
1997: Zincke H
[Adjuvant treatment after radical prostatectomy in prostatic carcinoma (pT3 or pTxN+): prognostic factors and results]
Praxis 1997;86(46):1825-32.
1997: Amling C L; Blute M L; Bergstralh E J; Slezak J M; Martin S K; Zincke H
Preoperative androgen-deprivation therapy for clinical stage T3 prostate cancer.
Seminars in urologic oncology 1997;15(4):222-9.
1997: Amling C L; Leibovich B C; Lerner S E; Bergstralh E J; Blute M L; Myers R P; Zincke H
Primary surgical therapy for clinical stage T3 adenocarcinoma of the prostate.
Seminars in urologic oncology 1997;15(4):215-21.
1997: Blute M L; Bostwick D G; Bergstralh E J; Slezak J M; Martin S K; Amling C L; Zincke H
Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
Urology 1997;50(5):733-9.
1997: Torres V E; Zincke H; King B K; Bjornsson J
Renal manifestations of tuberous sclerosis complex.
Contributions to nephrology 1997;122():64-75.
1996: Pisansky T M; Blute M L; Suman V J; Bostwick D G; Earle J D; Zincke H
Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens.
International journal of radiation oncology, biology, physics 1996;36(3):585-91.
1996: Lerner S E; Blute M L; Richardson R L; Zincke H
Platinum-based chemotherapy for advanced transitional cell carcinoma of the upper urinary tract.
Mayo Clinic proceedings. Mayo Clinic 1996;71(10):945-50.
1996: Lerner S E; Jacobsen S J; Lilja H; Bergstralh E J; Ransom J; Klee G G; Piironen T; Blute M L; Lieber M M; Zincke H; Pettersson K; Peterson D; Oesterling J E
Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate.
Urology 1996;48(2):240-8.
1996: Lerner S E; Blute M L; Bergstralh E J; Bostwick D G; Eickholt J T; Zincke H
Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy.
The Journal of urology 1996;156(1):137-43.
1996: Lerner S E; Hawkins C A; Blute M L; Grabner A; Wollan P C; Eickholt J T; Zincke H
Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
The Journal of urology 1996;155(6):1868-73.
1996: Kletscher B A; Qian J; Bostwick D G; Blute M L; Zincke H
Prospective analysis of the incidence of ipsilateral adrenal metastasis in localized renal cell carcinoma.
The Journal of urology 1996;155(6):1844-6.
1996: Lerner S E; Blute M L; Zincke H
Risk factors for progression in patients with prostate cancer treated with radical prostatectomy.
Seminars in urologic oncology 1996;14(2 Suppl 2):12-20; discussion 21.
1996: Lerner S E; Seay T M; Blute M L; Bergstralh E J; Barrett D; Zincke H
Prostate specific antigen detected prostate cancer (clinical stage T1c): an interim analysis.
The Journal of urology 1996;155(3):821-6.
1996: Pisansky T M; Zincke H; Suman V J; Bostwick D G; Earle J D; Oesterling J E
Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens.
International journal of radiation oncology, biology, physics 1996;34(1):33-9.
1995: Lerner S E; Blute M L; Zincke H
Extended experience with radical prostatectomy for clinical stage T3 prostate cancer: outcome and contemporary morbidity.
The Journal of urology 1995;154(4):1447-52.
1995: Hawkins C A; Bergstralh E J; Lieber M M; Zincke H
Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Urology 1995;46(3):356-64.
1995: Lerner S E; Mann B S; Blute M L; Richardson R L; Zincke H
Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: selection criteria and long-term results.
Mayo Clinic proceedings. Mayo Clinic 1995;70(9):821-8.
1995: Lerner S E; Blute M L; Zincke H
Critical evaluation of salvage surgery for radio-recurrent/resistant prostate cancer.
The Journal of urology 1995;154(3):1103-9.
1995: Torres V E; Björnsson J; King B F; Kumar R; Zincke H; Edell E S; Wilson T O; Hattery R R; Gomez M R
Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex.
Mayo Clinic proceedings. Mayo Clinic 1995;70(7):641-8.
1995: Zincke H; Ruckle H C
Use of exogenous material to bolster closure of the parenchymal defect following partial nephrectomy.
Urology 1995;46(1):96-8.
1995: Ruckle H C; Zincke H
Potency-sparing radical retropubic prostatectomy: a simplified anatomical approach.
The Journal of urology 1995;153(6):1875-7.
1995: Kletscher B A; Qian J; Bostwick D G; Andrews P E; Zincke H
Prospective analysis of multifocality in renal cell carcinoma: influence of histological pattern, grade, number, size, volume and deoxyribonucleic acid ploidy.
The Journal of urology 1995;153(3 Pt 2):904-6.
1995: Ferguson J K; Bostwick D G; Suman V; Zincke H; Oesterling J E
Prostate-specific antigen detected prostate cancer: pathological characteristics of ultrasound visible versus ultrasound invisible tumors.
European urology 1995;27(1):8-12.
1994: Zincke H; Bergstralh E J; Blute M L; Myers R P; Barrett D M; Lieber M M; Martin S K; Oesterling J E
Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2254-63.
1994: Zincke H; Oesterling J E; Blute M L; Bergstralh E J; Myers R P; Barrett D M
Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.
The Journal of urology 1994;152(5 Pt 2):1850-7.
1994: Ferguson J; Zincke H; Ellison E; Bergstrahl E; Bostwick D G
Decrease of prostatic intraepithelial neoplasia following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy.
Urology 1994;44(1):91-5.
1994: Velagapudi S R; Frydenberg M; Oesterling J E; Bergstralh E J; Moore S B; Ruckle H C; Zincke H
Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival.
Urology 1994;43(6):821-7.
1994: Blackwell K L; Bostwick D G; Myers R P; Zincke H; Oesterling J E
Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.
The Journal of urology 1994;151(6):1565-70.
1994: Hatcher P A; Hahn R G; Richardson R L; Zincke H
Neoadjuvant chemotherapy for invasive bladder carcinoma: disease outcome and bladder preservation and relationship to local tumor response.
European urology 1994;25(3):209-15.
1994: Kerr L A; Zincke H
Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis.
European urology 1994;25(4):305-11; discussion 311-2.
1994: Cheng W S; Bergstralh E J; Frydenberg M; Zincke H
Prostate-specific antigen levels after radical prostatectomy and immediate adjuvant hormonal treatment for stage D1 prostate cancer are predictive of early disease outcome.
European urology 1994;25(3):189-93.
1993: Henly D R; Farrow G M; Zincke H
Urachal cancer: role of conservative surgery.
Urology 1993;42(6):635-9.
1993: McLaren R H; Barrett D M; Zincke H
Rectal injury occurring at radical retropubic prostatectomy for prostate cancer: etiology and treatment.
Urology 1993;42(4):401-5.
1993: Cheng W S; Frydenberg M; Bergstralh E J; Larson-Keller J J; Zincke H
Radical prostatectomy for pathologic stage C prostate cancer: influence of pathologic variables and adjuvant treatment on disease outcome.
Urology 1993;42(3):283-91.
1993: Guthman D A; Wilson T M; Blute M L; Bergstralh E J; Zincke H; Oesterling J E
Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics.
Urology 1993;42(2):150-4.
1993: Oesterling J E; Andrews P E; Suman V J; Zincke H; Myers R P
Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor.
The Journal of urology 1993;149(4):779-82.
1993: Frydenberg M; Malek R S; Zincke H
Conservative renal surgery for renal cell carcinoma in von Hippel-Lindau's disease.
The Journal of urology 1993;149(3):461-4.
1993: Fain J S; Cosnow I; King B F; Zincke H; Bostwick D G
Cystosarcoma phyllodes of the seminal vesicle.
Cancer 1993;71(6):2055-61.
1993: Ruckle H C; Torres V E; Richardson R L; Zincke H
Renal tumors.
Current opinion in nephrology and hypertension 1993;2(2):201-10.
1993: Kleer E; Larson-Keller J J; Zincke H; Oesterling J E
Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade.
Urology 1993;41(3):207-16.
1993: Morgan W R; Bergstralh E J; Zincke H
Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer.
Urology 1993;41(2):113-20.
1993: Cheng C W; Bergstralh E J; Zincke H
Stage D1 prostate cancer. A nonrandomized comparison of conservative treatment options versus radical prostatectomy.
Cancer 1993;71(3 Suppl):996-1004.
1993: Stormont T J; Farrow G M; Myers R P; Blute M L; Zincke H; Wilson T M; Oesterling J E
Clinical Stage B0 or T1c prostate cancer: nonpalpable disease identified by elevated serum prostate-specific antigen concentration.
Urology 1993;41(1):3-8.
1992: Zincke H; Bergstralh E J; Larson-Keller J J; Farrow G M; Myers R P; Lieber M M; Barrett D M; Rife C C; Gonchoroff N J
Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
Cancer 1992;70(1 Suppl):311-23.
1992: Stormont T J; Bilhartz D L; Zincke H
Pitfalls of "bench surgery" and autotransplantation for renal cell carcinoma.
Mayo Clinic proceedings. Mayo Clinic 1992;67(7):621-8.
1992: Myers R P; Larson-Keller J J; Bergstralh E J; Zincke H; Oesterling J E; Lieber M M
Hormonal treatment at time of radical retropubic prostatectomy for stage D1 prostate cancer: results of long-term followup.
The Journal of urology 1992;147(3 Pt 2):910-5.
1992: Zincke H
Radical prostatectomy and exenterative procedures for local failure after radiotherapy with curative intent: comparison of outcomes.
The Journal of urology 1992;147(3 Pt 2):894-9.
1991: Nativ O; Reiman H M; Lieber M M; Zincke H
Treatment of primary squamous cell carcinoma of the upper urinary tract.
Cancer 1991;68(12):2575-8.
1991: Cheng W S; Farrow G M; Zincke H
The incidence of multicentricity in renal cell carcinoma.
The Journal of urology 1991;146(5):1221-3.
1991: Zincke H; Blute M L; Fallen M J; Farrow G M
Radical prostatectomy for stage A adenocarcinoma of the prostate: staging errors and their implications for treatment recommendations and disease outcome.
The Journal of urology 1991;146(4):1053-8.
1991: Rainwater L M; Zincke H; Farrow G M; Gonchoroff N J
Renal cell carcinoma in young and old patients. Comparison of prognostic pathologic variables (cell type, tumor grade and stage, and DNA ploidy pattern) and their impact on disease outcome.
Urology 1991;38(1):1-5.
1991: Morgan W R; Zincke H; Rainwater L M; Myers R P; Klee G G
Prostate specific antigen values after radical retropubic prostatectomy for adenocarcinoma of the prostate: impact of adjuvant treatment (hormonal and radiation)
The Journal of urology 1991;145(2):319-23.
1991: Nativ O; Bergstralh E J; Boyle E T; Zincke H
Transurethral resection versus needle biopsy prior to radical prostatectomy for stage C prostate cancer. Influence on progression and survival.
Urology 1991;37(1):22-7.
1990: Morgan W R; Zincke H
Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup.
The Journal of urology 1990;144(4):852-7; discussion 857-8.
1990: Zincke H
Combined surgery and immediate adjuvant hormonal treatment for stage D1 adenocarcinoma of the prostate: Mayo Clinic experience.
Seminars in urology 1990;8(3):175-83.
1990: Rainwater L M; Morgan W R; Klee G G; Zincke H
Prostate-specific antigen testing in untreated and treated prostatic adenocarcinoma.
Mayo Clinic proceedings. Mayo Clinic 1990;65(8):1118-26.
1990: Nativ O; Myers R P; Farrow G M; Therneau T M; Zincke H; Lieber M M
Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
The Journal of urology 1990;144(2 Pt 1):303-6.
1990: Montgomery B T; Nativ O; Blute M L; Farrow G M; Myers R P; Zincke H; Therneau T M; Lieber M M
Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
Archives of surgery (Chicago, Ill. : 1960) 1990;125(3):327-31.
1990: Keating J P; Zincke H; Hahn R G; Morgan W R
Extended experience of neo-adjuvant M-VAC chemotherapy for T1-4 N0 M0 transitional cell carcinoma of the urinary bladder.
Progress in clinical and biological research 1990;353():119-27.
1989: Blute M L; Nativ O; Zincke H; Farrow G M; Therneau T; Lieber M M
Pattern of failure after radical retropubic prostatectomy for clinically and pathologically localized adenocarcinoma of the prostate: influence of tumor deoxyribonucleic acid ploidy.
The Journal of urology 1989;142(5):1262-5.
1989: Nativ O; Winkler H Z; Raz Y; Therneau T M; Farrow G M; Myers R P; Zincke H; Lieber M M
Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Mayo Clinic proceedings. Mayo Clinic 1989;64(8):911-9.
1989: Blute M L; Segura J W; Patterson D E; Benson R C; Zincke H
Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer.
The Journal of urology 1989;141(6):1298-301.
1989: Zincke H
Extended experience with surgical treatment of stage D1 adenocarcinoma of prostate. Significant influences of immediate adjuvant hormonal treatment (orchiectomy) on outcome.
Urology 1989;33(5 Suppl):27-36.
1989: Goldwasser B; Zincke H
Modified Deschamps needle for securing dorsal vein complex and urethra during radical retropubic prostatectomy.
Urology 1989;33(4):324-6.
1988: Rainwater L M; Zincke H
Radical prostatectomy after radiation therapy for cancer of the prostate: feasibility and prognosis.
The Journal of urology 1988;140(6):1455-9.
1988: Stillwell T J; Zincke H; Gaffey T A; Woods J E
Malignant melanoma of the penis.
The Journal of urology 1988;140(1):72-5.
1988: Zincke H; Sen S E
Experience with extracorporeal surgery and autotransplantation for renal cell and transitional cell cancer of the kidney.
The Journal of urology 1988;140(1):25-7.
1988: Neves R J; Zincke H; Taylor W F
Metastatic renal cell cancer and radical nephrectomy: identification of prognostic factors and patient survival.
The Journal of urology 1988;139(6):1173-6.
1988: Siref L E; Zincke H
Radical cystectomy for historical and pathologic T1, N0, M0 (stage A) transitional cell cancer. Need for adjuvant systemic chemotherapy?
Urology 1988;31(4):309-11.
1988: Winkler H Z; Rainwater L M; Myers R P; Farrow G M; Therneau T M; Zincke H; Lieber M M
Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
Mayo Clinic proceedings. Mayo Clinic 1988;63(2):103-12.
1988: Zincke H; Sen S E; Hahn R G; Keating J P
Neoadjuvant chemotherapy for locally advanced transitional cell carcinoma of the bladder: do local findings suggest a potential for salvage of the bladder?
Mayo Clinic proceedings. Mayo Clinic 1988;63(1):16-22.
1987: Zincke H; Utz D C; Thulé P M; Taylor W F
Treatment options for patients with stage D1 (T0-3,N1-2,M0) adenocarcinoma of prostate.
Urology 1987;30(4):307-15.
1987: McDonald M W; Sterioff S; Engen D E; Zincke H; Kurtz S B
Renal transplantation in patients with indwelling continuous ambulatory peritoneal dialysis catheters.
The Journal of urology 1987;137(5):849-51.
1986: Sterioff S; Engen D E; Zincke H
Current status of renal transplantation--1986.
Mayo Clinic proceedings. Mayo Clinic 1986;61(7):573-8.
1985: Zincke H; Engen D E; Henning K M; McDonald M W
Treatment of renal cell carcinoma by in situ partial nephrectomy and extracorporeal operation with autotransplantation.
Mayo Clinic proceedings. Mayo Clinic 1985;60(10):651-62.
1985: McDonald M W; Zincke H; Engen D E; Sterioff S
Adaptation of existing cutaneous ureterostomy for urinary drainage after renal transplantation.
The Journal of urology 1985;133(6):1026-8.
1984: Johnson W J; Kurtz S B; Anderson C F; Mitchell J C; Zincke H; O'Fallon W M
Results of treatment of renal failure by means of home hemodialysis.
Mayo Clinic proceedings. Mayo Clinic 1984;59(10):663-8.
1984: Zincke H; Engen D E; Sterioff S; McDonald M W; Frohnert P P; Johnson W J
Improving results in primary diabetic renal transplantation.
Transplantation proceedings 1984;16(3):617-20.
1984: Torres V E; Velosa J A; Holley K E; Frohnert P P; Zincke H; Sterioff S
Meclofenamate treatment of recurrent idiopathic nephrotic syndrome with focal segmental glomerulosclerosis after renal transplantation.
Mayo Clinic proceedings. Mayo Clinic 1984;59(3):146-52.
1983: Okiye S E; Sterioff S; Schaff H V; Engen D E; Zincke H
Acute dissecting aneurysm of the aorta after renal transplantation.
The Journal of urology 1983;129(4):803-4.
1981: Sterioff S; Zincke H; Waltzer W C; Moore S B; Frohnert P P; Offord K P
Factors influencing outcome of kidney allografts from pretreated cadaveric donors.
Archives of surgery (Chicago, Ill. : 1960) 1981;116(1):73-7.
1980: Utz D C; Farrow G M; Rife C C; Segura J W; Zincke H
Carcinoma in situ of the bladder.
Cancer 1980;45(7 Suppl):1842-8.
1980: Waltzer W C; Coulam C B; Zincke H; Sterioff S; Frohnert P P
Pregnancy in renal transplantation.
Transplantation proceedings 1980;12(1):221-6.

Sign-in to see more